n Cardiovascular Journal of South Africa - VALUE study highlights the need for aggressive BP lowering in high-risk patients : drug trends in cardiology
|Article Title||VALUE study highlights the need for aggressive BP lowering in high-risk patients : drug trends in cardiology|
|© Publisher:||Clinics Cardive Publishing|
|Journal||Cardiovascular Journal of South Africa|
|Publication Date||Jul 2004|
|Pages||191 - 192|
Extracted from text ... 191 VALUE study highlights the need for aggressive BP lowering in high-risk patients Valsartan (Diovan(r)) achieves 23% reduction in new-onset diabetes and reduction in heart failure incidence and admissions in VALUE study The results of the VALUE (Valsartan Anti-hypertensive long-term use Evaluation) study, announced recently at the EHS (European Hypertension Society) Congress in Paris, will not only change the future of hypertension trials, 1 but will also add further impetus to the current emphasis on achieving target recommended BP control within a relatively short time, 2 according to the authors of the VALUE trial. The VALUE study of 15 ..
Article metrics loading...